We previously generated human PRDX4-transgenic mice (Tg mice) using C57BL/6 mice and reported that PRDX4 may have a protective role against the progression of atherosclerosis and nonalcoholic fatty liver disease via its antioxidant effect [19, 20]. Here, PRDX4 is linked to metabolic dysfunction-associated steatotic liver disease.